The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers prepare to meet growing…
Challenges and opportunities in delivering gene therapies for sickle cell disease and beta thalassemia
